Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02863666 · ClinicalTrials.gov registry record
Verification of Prediction Algorithm
A clinical trial, sponsored by Zoll Medical Corporation.
- Completed
- Registry status
- 673
- Enrollment target
NCT02863666: Completed study, sponsored by Zoll Medical Corporation.
NCT02863666 is a clinical trial that has completed, run by Zoll Medical Corporation. The registered enrollment target is 673 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02863666 has completed, sponsored by Zoll Medical Corporation.
- COMPLETED
- Registry status
- 673 participants
- Enrollment target
Study Summary
Prospective observational clinical study to verify an algorithm used to predict cardiopulmonary events in patients presenting to the emergency department.
Primary Outcome
The number of any cardiopulmonary event, not limited to: Cardiac arrest Sustained ventricular tachycardia (VT) Hypotension requiring inotropes or intra-aortic balloon pump (IABP) insertion Intubation or mechanical ventilation Complete heart block Bradycardia requiring insertion of a pacing wire or external pacing, and Percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 673 participants |
| Start Date | 2016-08-11 |
| Est. Completion | 2017-12-15 |
What the finished NCT02863666 record still lists
NCT02863666 is an observational study that tracks outcomes without assigning an intervention. The registered 673 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02863666 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02863666 about?
NCT02863666 is a clinical study titled "Verification of Prediction Algorithm". Prospective observational clinical study to verify an algorithm used to predict cardiopulmonary events in patients presenting to the emergency department.
What is the current status of trial NCT02863666?
This trial is currently completed. The enrollment target is 673 participants. The study started on 2016-08-11. Estimated completion is 2017-12-15.
Who is sponsoring clinical trial NCT02863666?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06335381 · 674 participants · NA
MOMs Chat and Care Study
- NCT06757634 · 674 participants · Phase 3
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- NCT05452031 · 672 participants · NA
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
- NCT05493254 · 672 participants · NA
Enhancing Smoking Cessation Via Telehealth Options in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI